Back to Search
ANNE-MARIE FLECKENSTEIN, PHD
PHD
Psychologist
NPI: 1386366391Individual
Specialties, Licenses & Credentials
Clinical Neuropsychologist
Clinical Neuropsychologist
Code: 103G00000X
20043612A(IN)
Health Service Psychologist
Psychologist — Health Service
Code: 103TH0100X
20043612B(IN)
PsychologistPrimary
Psychologist
Code: 103T00000X
20043612A(IN)
Research & Publications (20)
New insights into the mechanism of action of amphetamines.
PMID 17209801·Annu Rev Pharmacol Toxicol·2007
6-review
Impact of psychostimulants on vesicular monoamine transporter function.
PMID 14612158·Eur J Pharmacol·2003
6-review
Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.
PMID 11011026·Eur J Pharmacol·2000
6-review
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
PMID 19021208·Synapse·2009
7-preclinical
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.
PMID 18662707·Neuropharmacology·2009
6-review
Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue.
PMID 19464519·J Neurosci Methods·2009
7-preclinical
Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.
PMID 19038779·J Pharmacol Exp Ther·2009
7-preclinical
Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment.
PMID 19326567·Eur J Pharmacol·2009
7-preclinical
Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.
PMID 18992277·J Neurosci Methods·2009
7-preclinical
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
PMID 19141713·J Pharmacol Exp Ther·2009
7-preclinical
Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.
PMID 18591219·J Pharmacol Exp Ther·2008
7-preclinical
Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.
PMID 18991873·Ann N Y Acad Sci·2008
7-preclinical
Differential regional effects of methamphetamine on dopamine transport.
PMID 18599036·Eur J Pharmacol·2008
7-preclinical
The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
PMID 17250674·J Neurochem·2007
6-review
Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
PMID 17693585·J Pharmacol Exp Ther·2007
7-preclinical
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
PMID 17493052·Addiction·2007
6-review
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
PMID 17618619·Eur J Pharmacol·2007
7-preclinical
Persistence of tolerance to methamphetamine-induced monoamine deficits.
PMID 17239369·Eur J Pharmacol·2007
7-preclinical
Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
PMID 16480775·J Neurosci Methods·2006
7-preclinical
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
PMID 16687477·J Pharmacol Exp Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 355 W 16TH ST STE 2500
INDIANAPOLIS, IN 46202 - Phone
- (317) 963-7204
Quick Facts
- NPI
- 1386366391
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile